Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
This study has been completed.
Study NCT00169637   Information provided by Hospices Civils de Lyon
First Received: September 12, 2005   Last Updated: October 30, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Short Bowel Syndrome
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Digestive System Diseases
Disease
Gastrointestinal Diseases
Intestinal Diseases
Malabsorption Syndromes
Pathologic Processes
Postoperative Complications
Interventions listed in this trial
rhGH
Additional drug interventions recognized in this trial
Hormones
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Hospices Civils de Lyon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services